The weight loss drug Belvique has been withdrawn from the market by its producer, Esai Pharmaceuticals After post-marketing studies revealed an increased risk of cancer.
The FDA approved the drug for routine prescription, but only if the maker conducted “post-marketing” study of a potential cancer risk identified in preliminary research. That five year follow up study revealed an increased risk of cancer among those taking the approved drug. This is another example of why “approved” does not mean fully tested.
All medical decisions should be made with your full collaboration and understanding of the benefits, risks, alternatives, and unknowns of the treatment being prescribed.
If you would like to learn more about how we can help educate you about medical facts, or coach you to collaborate better with your doctor regarding your medical decisions, email us or call 203-692-4422 for a free introductory consultation.